Phase 1 First-In-Human Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 794 in Subjects With Claudin 6- positive Advanced/Metastatic Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor Indications

Project: Research

Project Details

StatusActive
Effective start/end date4/07/23 → 3/07/25

Keywords

  • Clinical trial
  • 20210007